glp 1 lilly Eli Lilly's oral GLP-1 pill may help people with Type 2 diabetes lose 'significant' weight, study finds FDA approval for Zepbound (tirzepatide)

Discover timing, food restrictions, and absorption tips for better non-injection results.

Mean INR did not change (0.00

Those with obesity might have other serious chronic health conditions, including diabetes and high blood pressure, which are leading risk factors for heart disease and stroke

For local players, this reinforces the role of licensing and distribution alliances as a practical path to compete in the global #obesity market ahead of full-scale innovation or manufacturing build-out

Indias pharma industry is strong

As the GLP-1 product market continues to expand, manufacturers must find ways to differentiate their inline and pipeline assets with new evidence and strong value story.